Invivyd Announces Initiation of DECLARATION Clinical Trial, a Phase 3 Placebo-Controlled Pivotal Study of VYD2311, a Vaccine-Alternative Antibody to Prevent COVID

DECLARATION is a Phase 3, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of VYD2311 in the prevention of COVID ...
Nature

Intramuscular Injection Techniques and Sciatic Nerve Injury

Intramuscular injection remains a cornerstone of clinical practice, offering rapid drug absorption and efficacy when performed correctly. However, its success is intrinsically linked to precise ...

Invivyd Earns Fast Track Designation for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID

NEW HAVEN, Conn., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for VYD2311, an ...
Medscape

Meningioma Warning Added to Depo-Provera Label

The action follows mounting scientific evidence linking the injectable contraceptive medication to an increased risk for meningioma.

Foresee Pharmaceuticals announces the Casppian Phase 3 Study Meets Primary Efficacy Endpoint, Demonstrating Robust LH Suppression with 6-Month Dosing Interval of leuprolide ...

FP-001 42 mg is an investigational, sustained-release formulation of a GnRH agonist being developed for the treatment of CPP. It is designed to provide continuous suppression of gonadotropin secretion ...
STAT

FDA approves first new kind of drug to target gonorrhea in decades

Zoliflodacin, which will be marketed under the name Nuzolvence, is the first new drug to uniquely target gonorrhea infections ...
Nanowerk

A single-atom tweak to mRNA vaccine lipids boosts cancer immunotherapy

Changing just one atom in a COVID-19 vaccine lipid redirects delivery from the liver to the spleen, improving tumor ...
STAT

Pharmalittle: We’re reading about FDA approval for a novel antibiotic, setbacks at Sanofi, and much more

Sanofi flagged a second delay to an FDA decision for its experimental multiple sclerosis drug and reported disappointing ...
Investing.com South Africa

Invivyd stock rises after FDA grants Fast Track designation for COVID antibody

Investing.com -- Invivyd shares rose about 2.4% in premarket trading after the company announced that the U.S. Food and Drug Administration has granted Fast Track designation for its COVID-19 ...
pharmaphorum

MSD, Moderna take mRNA jab into phase 3 for lung cancer

MSD and partner Moderna have started a late-stage trial of their personalised cancer vaccine V940 as a combination with MSD’s PD-1 inhibitor Keytruda for patients with non-small cell lung cancer ...
The American Journal of Managed Care

HIV in 2025 Defined by Challenges Throughout the Year, Despite Some Advances

The Trump administration's funding cuts to PEPFAR and USAID disrupted global HIV treatment and prevention, threatening progress made over decades. Lenacapavir's FDA approval as a long-acting ...
MedPage Today on MSN

For Your Patients: What to Know About the Newest Treatments for HR+/HER2- Breast Cancer

The first-line standard of care for HR-positive/HER2-negative breast cancer is cyclin-dependent kinase (CDK)4/6 inhibitors combined with endocrine therapy (ET). This dual-therapy targets a pathway ...